latest news today

Risk of heart attack covid vaccines

FDA Adds New Details to Warning Labels

Warnings now include expanded risk data for myocarditis, affecting a broader age range: 6 months to 64 years.

corona updates

Understanding the Risk 

What Is Myocarditis?

Myocarditis is a rare heart inflammation, usually mild. It emerged as a complication after COVID-19 vaccines began rolling out in 2021.

What’s the Risk?

2

The updated label states a risk of 8 cases of myocarditis per 1 million people aged 6 months to 64 years who received the 2023–2024 COVID shots. The FDA has updated labels on Pfizer and Moderna COVID-19 vaccines to include more detailed warnings about rare heart inflammation risks, especially in young men.

Young Males Most Affected

Cases of myocarditis are most common in males aged 12 to 24, expanding the previous focus on ages 12 to 17.

2

FDA vs CDC Findings

CDC data shows no increased risk of myocarditis from vaccines since 2022 and states vaccine-related cases are usually mild and temporary.

New Vaccine Policy Controversy

Content:

The update comes as RFK Jr.'s new CDC panel questions vaccine use in key groups, including pregnant women, drawing criticism from public health experts.

What’s Next for COVID Vaccines?

U.S vaccine policy

FDA leadership is restricting annual shots to high-risk groups and suggesting new testing for updated vaccines, signaling a shift in U.S. vaccine policy.

2